NEWS
Lack of sleep leads to obesity in children and adolescents
Children who get less than the recommended amount of sleep for their age are at a higher risk of developing...
Two is better than one to improve brain function in Alzheimer’s disease mouse model
Credit: J. Exp. Med./ Dr. J. Jankowsky Using two complementary approaches to reduce the deposits of amyloid-beta in the brain...
Mosquitoes reveal fatal attraction
Malaria causes the bodies of its human hosts to emit specific odours from the skin that make the hosts even...
Innate immune adaptor TRIF confers neuroprotection in ALS
Credit: Koji Yamanaka Nagoya, Japan - Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease damaging motor neurons in brain and...
New liquid biopsy-based cancer model reveals data on deadly lung cancer
Credit: MD Anderson Cancer Center Small cell lung cancer (SCLC) accounts for 14 percent of all lung cancers and is...
Stand Up To Cancer takes new approach to multiple myeloma focusing on precursor conditions
Credit: Stand Up To Cancer CHICAGO - April 15, 2018 -- Stand Up To Cancer announced a $10 million award...
Announcing the Pancreatic Cancer Collective
Chicago (April 15, 2018) -- The Lustgarten Foundation and Stand Up To Cancer (SU2C) announced today at the Annual Meeting...
First-in-human clinical trial of new targeted therapy drug reports promising responses for multiple
Credit: MD Anderson Cancer Center A phase I, first-in-human study led by The University of Texas MD Anderson Cancer Center...
Australia to join global health and climate change initiative
The Lancet Countdown report on health and climate change was published in October 2017 by The Lancet and will be...
Painkillers in pregnancy may affect baby’s future fertility
Taking painkillers during pregnancy could affect the fertility of the unborn child in later life, research suggests. The study identifies...
2018 AACR Annual Meeting presentations highlight the clinical utility of Bio-Rad’s Droplet Digital PCR technology for discovering epigenetic biomarkers and measuring immunotherapy response
HERCULES, Calif. -- April 14, 2018 -- New research showcasing the importance of Bio-Rad's Droplet Digital PCR (ddPCR) technology in...
Fecal microbiota transplantation produces sustained improvements in cognitive and clinical outcomes
14 April 2018, Paris, France: A single treatment using an optimized, targeted form of faecal microbiota transplantation (FMT) produces sustained...
Updates on new therapies in development for rare liver diseases
14 April 2018, Paris, France: Promising results for three drugs for the treatment of three rare liver diseases were presented...
Pulsed corona discharge removes pharmaceutical residues from wastewater
A doctoral dissertation to undergo a public examination at Lappeenranta University of Technology (LUT) examines the removal of harmful organic...
‘Tic-tac-toe’-themed MRI technology easy win for neurological disease researchers
Credit: University of Pittsburgh Radiofrequency Research Facility PITTSBURGH (April 12, 2018) ... The University of Pittsburgh houses a whole-body 7...
Budesonide add-on therapy improves markers of disease activity but fails to improve histology in patients with primary biliary cholangitis
13 April 2018, Paris, France: The addition of budesonide is associated with clinically meaningful improvements in biochemical markers of disease...
NGM282 — an engineered analogue of FGF19 — shows promise in patients with primary sclerosing cholangitis
13 April 2018, Paris, France: The fibroblast growth factor 19 (FGF19) engineered analogue, NGM282, inhibits bile acid synthesis, decreases markers...
Selective internal radiation therapy (SIRT) fails to extend survival in the SORAMIC study palliative cohort
13 April 2018, Paris, France: The final results of the palliative cohort of the SORAMIC study in patients with unresectable,...
To starve pancreatic tumors, researchers seek to block ‘self-eating,’ other fuel sources
CHAPEL HILL -- To get the extra energy they need to fuel their uncontrolled growth, cancer cells break down some...
Phase 2 studies of two novel treatments for primary biliary cholangitis report encouraging results
ILC 2018: Ongoing Phase 2 studies of tropifexor and seladelpar report promising preliminary efficacy, safety and tolerability results, paving the...
